Global Longlife Hospital and Research Limited (BSE: 543520)
Health Care · Health Care Providers & Services · IN
Rs12.04
-7.67% today · -49.8% 1Y
Global Longlife Hospital and Research Limited (BSE: 543520) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.32M.
Over the last twelve months the share price has lost 49.8%, trading between 9.00 and 26.73.
Tweenvest scores Global Longlife Hospital and Research Limited across four factors: quality 63/100. Its strongest factor is quality.
543520 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.32M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.64
- Dividend yield
- —
- Beta (5Y)
- -0.18
- 52-week high
- Rs26.73
- 52-week low
- Rs9.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.50M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $397.55 | +0.24% |
| CVS Health CorporationNYSE: CVS | $118.82B | $93.00 | +0.11% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.09 | +3.58% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $398.87 | -0.93% |
| The Cigna GroupNYSE: CI | $73.81B | $279.32 | -0.40% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.92 | +2.39% |
Figures last refreshed Aug 18, 2026.